The Effect of Nitrate on Brown Fat

NCT ID: NCT05342012

Last Updated: 2023-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-30

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Type 2 diabetes mellitus (T2DM) is a metabolic condition characterized by chronic hyperglycemia and progressive insulin resistance, which progressively lead to macro- and microvascular damage. With the number of people with T2DM continuing to rise, this pandemic is expected to reach 700 million people by 2045, such that the costs associated with its clinical management are likely to become unsustainable. Therefore, identifying cost effective alternative interventions is imperative.

Diets rich in fruits and vegetables are well known to have cardiovascular benefits and reduce the risk of getting T2DM. The beneficial effects of vegetables on cardiovascular outcomes are particularly effective in green leafy vegetables and beetroot. This may in part be due to a high concentration of inorganic nitrate, and its beneficial effects on cardiovascular health due to its effect on nitric oxide (NO•). Increased dietary nitrate intake elevates cyclic guanosine monophosphate \[(cGMP)\]. Importantly, cGMP has also been shown to increase brown fat expression by 'beiging' WAT in mice through an NO• dependent process.

Recent developments in the ability to non-invasively measure BAT activation using magnetic resonance imaging (MRI) and infrared thermography (ITR) has opened the possibility to study the effects of nitrate on BAT activation in man. BAT depots in humans with T2DM have been identified using MRI but not yet with the more easily accessible technique of IRT.

It is hypothesised that nitrate can increase BAT activation and quantity in people with T2DM.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dietary inorganic nitrate is converted in a reversible, stepwise reaction to nitrite via bacteria on the dorsum of the tongue. Subsequently, small quantities of NO• are produced in the stomach. The remaining nitrite is then absorbed into the circulation where it acts as a storage pool for subsequent NO• production. Production of NO• from nitrite reduction is expedited in hypoxaemia, a phenomenon observed in the vasculature of white adipose tissue (WAT).

WAT is primarily an energy store, whereas brown adipose tissue (BAT) is a metabolically active tissue. BAT is responsible for \~5% of basal metabolic rate and \~15% of total energy expenditure, equating to \~40 g of BAT per day and is used in non-shivering thermogenesis. BAT is used for heat production and is stimulated by cold environments and or diet to cause thermogenesis. To produce heat during cold exposure, uncoupling protein (UCP)-1, an inner mitochondrial protein, is upregulated in BAT ultimately uncoupling the mitochondrial proton gradient, making the cell less energy efficient. Inorganic nitrate supplementation has also been shown to increase UCP-1 expression in BAT.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Double blind randomised control trial. Supplements will be dispensed by a member of the research team.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental: Beetroot juice then nitrate depleted beetroot juice

Participants will be asked to consume 140ml of beetroot juice prior to their first experimental visit. Participants will then be asked to consume 140ml a day for 2 weeks, and finally visit the investigators once more following another 140ml drink.

Group Type EXPERIMENTAL

Concentrated beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Acute and chronic supplementation of beetroot juice.

Nitrate depleted beetroot juice

Intervention Type DIETARY_SUPPLEMENT

(Nitrate depleted beetroot juice

Experimental: Nitrate depleted beetroot juice then beetroot juice

Participants will be asked to consume 140ml of placebo prior to their first experimental visit. Participants will then be asked to consume 140ml a day for 2 weeks, and finally visit the investigators once more following another 140ml drink.

Group Type EXPERIMENTAL

Concentrated beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Acute and chronic supplementation of beetroot juice.

Nitrate depleted beetroot juice

Intervention Type DIETARY_SUPPLEMENT

(Nitrate depleted beetroot juice

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Concentrated beetroot juice

Acute and chronic supplementation of beetroot juice.

Intervention Type DIETARY_SUPPLEMENT

Nitrate depleted beetroot juice

(Nitrate depleted beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males or women with Type 2 Diabetes Mellitus

Exclusion Criteria

* Individuals with a BMI over 30
* Individuals with severe claustrophobia (this would make imaging the BAT less reliable)
* Current smokers (or those that have smoked within 3 months)
* Proton pump inhibitors or phosphodiesterase inhibitor users, as these may affect \[cGMP\]. Half life of this drug is short. Participants can choose to not use this if they wish to participate.
* Individuals with any other serious medical condition which would interfere with data interpretation or safety will be excluded from participation.
* Unable to give informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Portsmouth

OTHER

Sponsor Role collaborator

Institute of Bioengineering and Bioimaging (IBB)

OTHER_GOV

Sponsor Role collaborator

Loughborough University

OTHER

Sponsor Role collaborator

Bournemouth University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rebecc Neal

Role: STUDY_CHAIR

Senior Lecturer in Exercise Physiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bournemouth University

Bournemouth, Dorset, United Kingdom

Site Status

University of Portsmouth

Portsmouth, Hampshire, United Kingdom

Site Status

Southern Health NHS Foundation Trust

Southampton, Hampshire, United Kingdom

Site Status

Shore Medical

Poole, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

306840

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Beetroot Juice and Sleep
NCT05864521 RECRUITING NA